Mango Modulates Blood Glucose Similar to Rosiglitazone without Compromising Bone Parameters in Mice Fed High Fat Diet


 Mango, high fat diet, rosiglitazone, bone.

How to Cite

Edralin A. Lucas, Angela Brown, Wenjia Li, Sandra K. Peterson, Yan Wang, Penny Perkins-Veazie, Stephen L. Clarke, & Brenda J. Smith. (2012). Mango Modulates Blood Glucose Similar to Rosiglitazone without Compromising Bone Parameters in Mice Fed High Fat Diet. Journal of Pharmacy and Nutrition Sciences, 2(2), 115–126.


Both consumption of high-fat diet and one of the commonly used pharmacological therapies for modulating blood glucose, rosiglitazone, are associated with negative effects on bone. Previously, we reported that a diet supplemented with freeze-dried mango modulated blood glucose similar to rosiglitazone in mice fed a high-fat (HF) diet. This study examined the effects of the addition of freeze-dried mango pulp or rosiglitazone to a HF diet on bone parameters in mice. Six week old male C57BL/6J mice were randomly assigned into one of five dietary treatment groups (n=8-9 mice/group): control (9.5% calories from fat), HF (58.9% calories from fat), HF+1% or 10% mango (w/w), and HF+rosiglitazone (50 mg/kg diet) for eight weeks. Bone parameters were assessed via dual energy x-ray absorptiometry and micro-computed tomography. Both the HF and HF+rosiglitazone groups had lower whole body, tibial, and vertebral bone mineral density compared to the HF+1% mango group. Trabecular bone volume, number, and separation as well as bone strength were also compromised by HF+rosiglitazone while the mango diets maintained these bone microarchitecture parameters to that observed in the control group. These results suggests that addition of mango to the diet may provide an alternative approach to modulating blood glucose without negatively affecting skeletal health, though human studies are needed to confirm these findings. Additionally, the bioactive component(s) in mango and the mechanisms by which it modulates blood glucose and exerts potentially osteoprotective benefits warrants further investigation.


Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr 2010; 29: 289S-301S.

Papaioannou A, Kennedy CC, Cranney A, et al. Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 2009; 20: 507-18.

Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Min Res 2001; 16: 182-8.

Wohl GR, Loehrke L, Watkins BA, Zernicke RF. Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int 1998; 63: 74-9.

Kalaitzidis RG, Sarafidis PA, Bakris GL. Effects of thiazolidinediones beyond glycaemic control. Curr Pharm Des 2009; 15: 529-36.

Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 2007; 148: 2669-80.

Murphy CE, Rodgers PT. Effects of thiazolidinediones on bone loss and fracture. Ann Pharmacother 2007; 41: 2014-8.

Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka- Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004; 145: 401-6.

Schwartz AV, Sellmeyer DE. Effect of thiazolidinediones on skeletal health in women with type 2 diabetes. Expert Opin Drug Saf 2008; 7: 69-78.

Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM. Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 2004; 79: 155-65.

Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999; 69: 727-36.

Ullah MF, Khan MW. Food as medicine: potential therapeutic tendencies of plant derived polyphenolic compounds. Asian Pac J Cancer Prev 2008; 9: 187-95.

Devareddy L, Hooshmand S, Collins JK, Lucas EA, Chai SC, Arjmandi BH. Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. J Nutr Biochem 2008; 19: 694-9.

Halloran BP, Wronski TJ, VonHerzen DC, et al. Dietary dried plum increases bone mass in adult and aged male mice. J Nutr 2010; 140: 1781-7.

Chen JR, Lazarenko OP, Wu X, et al. Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/?-catenin canonical Wnt signaling. J Bone Miner Res 2010; 25: 2399- 411.

Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112: 915-23.

Remer T, Manz F, Alexy U, Schoenau E, Wudy SA, Shi L. Long-term high urinary potential renal acid load and low nitrogen excretion predict reduced diaphyseal bone mass and bone size in children. J Clin Endocrinol Metab 2011; 96: 2861-8.

Banfi G, Iorio EL, Corsi MM. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 2008; 46: 1550-5.

Graham LS, Tintut Y, Parhami F, et al. Bone density and hyperlipidemia: the T-lymphocyte connection. J Bone Miner Res 2010; 25: 2460-9.

U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 18. 2005

Aderibigbe AO, Emudianughe TS, Lawal BAS. Evaluation of the antidiabetic action of Mangifera indica in mice. Phytother Res 2001; 15: 456-8.

Aderibigbe AO, Emudianughe TS, Lawal BAS. Antihyperglycaemic effect of Mangifera indica in rat. Phytother Res 1999; 13: 504-7. 1573(199909)13:6<504::AID-PTR533>3.0.CO;2-9

Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 2005; 97: 497-501.

Ojewole JA. Antiinflammatory, analgesic and hypoglycemic effects of Mangifera indica Linn. (Anacardiaceae) stem-bark aqueous extract. Methods Find Exp Clin Pharmacol 2005; 27: 547-54.

Percival SS, Talcott ST, Chin ST, Mallak AC, Lounds- Singleton A, Pettit-Moore J. Neoplastic transformation of BALB/3T3 cells and cell cycle of HL-60 cells are inhibited by mango (Mangifera indica L.) juice and mango juice extracts. J Nutr 2006; 136: 1300-4.

Carvalho RR, Pellizzon CH, Justulin L Jr, et al. Effect of mangiferin on the development of periodontal disease: Involvement of lipoxin A4, anti-chemotaxic action in leukocyte rolling. Chem Biol Interactt 2009; 179: 344-50.

Ang E, Liu Q, Qi M, et al. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-?B and ERK. J Cell Biochem 2011; 112: 89- 97.

Lucas EA, Li W, Peterson SK, et al. Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet. Br J Nutr 2011; 28: 1-11.

Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-51.

Molnar J, Yu S, Mzhavia N, Pau C, Chereshnev I, Dansky HM. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 2005; 96: 1178-84.

Manthey J, Perkins-Veazie P. Influences of harvest date and location on the levels of B-carotene, ascorbic acid, total phenols, the in vitro antioxidant capacity, and phenolic profiles of five commercial varieties of mango (Mangifera indica L.). J Agric Food Chem 2009; 57: 10825-30.

Lucas EA, Juma S, Stoecker BJ, Arjmandi BH. Prune suppresses ovariectomy-induced hypercholesterolemia in rats. J Nutr Biochem 2000; 11: 255-9.

Bobek P, Ginter E, Jurcovicova M, Ozdin L, Cerven J, Babala J. Effect of dehydrated apple products on the serum and liver lipids in Syrian hamsters. Nahrung 1990; 34: 783-9.

Prior RL, Wu X, Gu L, Hager TJ, Hager A, Howard LR. Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem 2008; 56: 647-53.

Chao L, Marcus-Samuels B, Mason MM, et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 2000; 106: 1221-8.

Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994; 17: 152-4.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.

Lee S, Muniyappa R, Yan X, et al. Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. Am J Physiol Endocrinol Metab 2008; 294: E261-70.

Newitt DC, Majumdar S, van Rietbergen B, et al. In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius. Osteoporos Int 2002; 13: 6-17.

Lac G, Cavalie H, Ebal E, Michaux O. Effects of a high fat diet on bone of growing rats. Correlations between visceral fat, adiponectin and bone mass density. Lipids Health Dis 2008; 28:16-20.

Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005; 146: 1226-35.

Wilkinson AS, Monteith GR, Shaw PN, Lin CN, Gidley MJ, Roberts-Thomson SJ. Effects of the mango components mangiferin and quercetin and the putative mangiferin metabolite norathyriol on the transactivation of peroxisome proliferator-activated receptor isoforms. J Agric Food Chem 2008; 56: 3037-42.

Li H, Miyahara T, Tezuka Y, et al. The effect of Kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of of Tsu-kan-gan. Biol Pharm Bull 1998; 21: 1322-6.

Berardini N, Knödler M, Schieber A, Carle R. Utilization of mango peels as a source of pectin and polyphenolics. Inn Food Sci Emer Tech 2005; 6: 442-52.

Prior RL, Wilkes S, Rogers T, Khanal RC, Wu X, Howard LR. Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J Agric Food Chem 2010; 58: 3970-

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2012 Edralin A. Lucas, Angela Brown, Wenjia Li, Sandra K. Peterson, Yan Wang, Penny Perkins-Veazie, Stephen L. Clarke , Brenda J. Smith